Home › Funds › Capital Group › Global Growth Fund
Fund family: Capital Group · Filed by AMERICAN FUNDS INSURANCE SERIES (CIK 729528) · SEC series S000008786
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 2,443 with, 101 against, 6 abstentions (not counted as with management); 27 items carried no recommendation. Shareholder proposals: 39 FOR, 77 AGAINST, 1 abstained, by the filing’s own vote-source field.
The same two figures as Capital Group’s manager page (120,065 ballot items across 80 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Capital Group | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 96.5% | 2,071 | 96.6% | 98,284 |
| Backed environmental and social shareholder proposals at US companies | 0.0% | 51 | 1.3% | 2,130 |
Each ballot item this fund voted is set against the votes of the other Capital Group funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most Capital Group funds on 14 items (0.6% of the 2,219 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most Capital Group funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Novo Nordisk A/S | 2026-03-26 | Reelect Cees de Jong (Vice Chair) as Director | For | ABSTAIN — 11 of 12 Capital Group funds | For | — |
| BeOne Medicines Ltd. | 2026-06-11 | THAT Dr. Felix J. Baker be and is hereby elected to serve as a director of the Company for a term extending until completion of the 2027 annual general meeting. | For | AGAINST — 6 of 6 Capital Group funds | For | Elected, 83.3% support |
| BeOne Medicines Ltd. | 2026-06-11 | THAT the granting of a share issue mandate to the Board of Directors to issue, allot or deal with unissued ordinary shares and/or American Depositary Shares ("ADSs") (including any sale or transfer of treasury shares out of treasury) not exceeding 20% of the total number of issued shares of the Comp | Against | FOR — 6 of 6 Capital Group funds | Against | Approved, 70.0% support |
| LVMH Moet Hennessy Louis Vuitton SE | 2026-04-23 | Approve Compensation of Bernard Arnault, Chairman and CEO | For | AGAINST — 15 of 18 Capital Group funds | For | — |
| LVMH Moet Hennessy Louis Vuitton SE | 2026-04-23 | Renew Appointment of Diego Della Valle as Censor | For | AGAINST — 15 of 18 Capital Group funds | For | — |
| LVMH Moet Hennessy Louis Vuitton SE | 2026-04-23 | Renew Appointment of Lord Powell of Bayswater as Censor | For | AGAINST — 15 of 18 Capital Group funds | For | — |
| Amazon.com, Inc. | 2026-05-20 | ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION | Against | FOR — 17 of 24 Capital Group funds | Against | Approved, 94.0% support |
| Shopify Inc. | 2026-06-16 | Shareholder Adopt a Policy on Responsible Use of Artificial Intelligence ("AI") in the Company's Business and Operations | For | AGAINST — 9 of 12 Capital Group funds | Against | — |
| UnitedHealth Group Incorporated | 2026-06-01 | Election of Directors: Scott Gottlieb, M.D. | Against | FOR — 13 of 19 Capital Group funds | Against | Elected, 93.0% support |
| The Sherwin-Williams Company | 2026-04-22 | Election of 9 Directors: Jeff M. Fettig | Against | FOR — 3 of 3 Capital Group funds | Against | Elected, 96.9% support |
| Oracle Corporation | 2025-11-18 | Advisory Vote to Approve the Compensation of our Named Executive Officers | Against | FOR — 15 of 25 Capital Group funds | Against | Passed (calculated), 81.9% support |
| Novo Nordisk A/S | 2026-03-26 | Elect Helena Saxon as New Director | For | ABSTAIN — 8 of 12 Capital Group funds | For | — |
| Carvana Co. | 2026-05-05 | To ratify the appointment of Grant Thornton LLP as Carvana's independent registered public accounting firm for the year ending December 31, 2026. | For | AGAINST — 5 of 9 Capital Group funds | For | Approved, 98.6% support |
| Dollar General Corporation | 2026-05-28 | Shareholder To vote on a shareholder proposal asking the Board to amend the director resignation policy to require directors who do not receive a majority vote in uncontested elections to leave the Board within nine months. | Against | FOR — 2 of 3 Capital Group funds | For | Not approved, 15.5% support |
Download all 14 differences (CSV)
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 1,251 | 0 |
| Corporate Governance | 406 | 36 |
| Compensation | 302 | 4 |
| Capital Structure | 267 | 0 |
| Audit-related | 172 | 0 |
| Say-on-Pay | 80 | 0 |
| Other Social Issues | 31 | 24 |
| Environment or Climate | 22 | 21 |
| Extraordinary Transactions | 20 | 0 |
| Human Rights or Human Capital/workforce | 11 | 11 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Microsoft Corporation | December 5, 2025 | $399M | 21 | 6 |
| Broadcom Inc. | April 20, 2026 | $323M | 10 | 0 |
| Micron Technology, Inc. | January 15, 2026 | $312M | 12 | 1 |
| Meta Platforms, Inc. | May 27, 2026 | $260M | 22 | 9 |
| Alphabet Inc. | June 5, 2026 | $161M | 23 | 10 |
| Starbucks Corporation | March 25, 2026 | $137M | 19 | 5 |
| Citigroup Inc. | May 20, 2026 | $131M | 16 | 0 |
| NVIDIA Corporation | June 24, 2026 | $124M | 16 | 4 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| December 5, 2025 | Microsoft Corporation | European Security Program Censorship Risk Audit Shareholder proposal | Against | For |
| December 5, 2025 | Microsoft Corporation | Report on Risks of Censorship in Generative Artificial Intelligence Shareholder proposal | Against | For |
| January 15, 2026 | Micron Technology, Inc. | SHAREHOLDER PROPOSAL REQUESTING AMENDMENT TO SHAREHOLDER SPECIAL MEETING RIGHT. Shareholder proposal | For | Against |
| May 27, 2026 | Meta Platforms, Inc. | A shareholder proposal regarding report on Al data usage oversight. Shareholder proposal | Against | For |
| May 27, 2026 | Meta Platforms, Inc. | A shareholder proposal regarding annual vote regarding executive pay. Shareholder proposal | For | Against |
| June 5, 2026 | Alphabet Inc. | Shareholder proposal regarding an enhanced disclosure on climate goals Shareholder proposal | Against | For |
| June 5, 2026 | Alphabet Inc. | Shareholder proposal regarding a report on water usage and AI development Shareholder proposal | Against | For |
| March 25, 2026 | Starbucks Corporation | Shareholder proposal requesting adoption of an independent board chair policy Shareholder proposal | Against | For |
| March 25, 2026 | Starbucks Corporation | Shareholder proposal requesting a report on the Company's apparent exclusion of detransitioning in its healthcare coverage Shareholder proposal | Against | For |
| June 24, 2026 | NVIDIA Corporation | Approval of a non-binding stockholder proposal requesting the replacement of supermajority voting provisions in our charter and bylaws with a simple majority voting standard. Shareholder proposal | For | Against |
| June 24, 2026 | NVIDIA Corporation | Approval of a non-binding stockholder proposal requesting a report on faith-based community resource groups. Shareholder proposal | Against | For |
| May 13, 2026 | Vertex Pharmaceuticals Incorporated | Shareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written consent. Shareholder proposal | For | Against |
2,581 ballot items at 186 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Global Growth Fund voted at 186 shareholder meetings of 168 companies, on 2,581 ballot items in all. Where management made a recommendation, the fund followed it on 95.8% of the items and voted against it 101 times. Its most frequent area of disagreement was corporate governance (36 of its votes against management). It voted FOR 33.6% of the 116 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals about as often as Capital Group's funds as a whole (96.5% against 96.6%). It voted differently from most Capital Group funds on 14 items.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Capital Group’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.